Tag Archives: Earnings

Thursday, June 13th 2019 at 8:05pm UTC Update on SDC-Based Antimicrobial Food Safety Solutions SAN DIEGO–(BUSINESS WIRE)– PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month period ended April 30, 2019. Q3: Summary …

Thursday, June 13th 2019 at 8:05pm UTC IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)– Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today reported financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2019. Recent Business …

Monday, June 10th 2019 at 8:05pm UTC Conference call to be held June 11 at 11:00 a.m. ET PRINCETON, N.J.–(BUSINESS WIRE)– Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced an update on its clinical pipeline and financial results for the …

Monday, June 10th 2019 at 8:17pm UTC Company Outlines Three-Pronged Short-Term Value Creation and Growth Strategy Intellectual Property Settlements Generate Approximately $30 Million in Cash in the Third Quarter NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ), an integrated life sciences company focused on commercializing innovative diagnostic and therapeutics products, today reported …

Thursday, June 6th 2019 at 10:59am UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the second quarter of 2019 on Thursday, July 25, 2019. During a conference call at 10:30 a.m. ET on July 25, company executives will review financial information and will address inquiries from …

Thursday, June 6th 2019 at 12:00pm UTC IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)– Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced it will report financial results for the fourth fiscal quarter and full fiscal year ended March 31, …

Wednesday, June 5th 2019 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2019 third quarter results Tuesday, June 11, 2019, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. When prompted, use …

Tuesday, June 4th 2019 at 12:00pm UTC PRINCETON, N.J.–(BUSINESS WIRE)– Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that the company will host a business update call on Tuesday, June 11, 2019 at 11:00 a.m. ET. During the call, Advaxis’ …

Friday, May 31st 2019 at 10:57pm UTC TORONTO–(BUSINESS WIRE)– Organic Garage Ltd. (“Organic Garage” or the “Company”) (TSX-V:OG) has released the Company’s annual audited financial results for its year ended January 31 2019. The Company’s audited annual consolidated financial statements for the Company including the operating company and all subsidiaries …

Friday, May 31st 2019 at 5:14am UTC BELGRADE, Mont.–(BUSINESS WIRE)– Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q2 2019. Sales and Product Offerings Completion of the relocated processing facility to Belgrade, Montana and expanding reach into dental markets. Gross profit margin …